CD8A and neoplasm: Lymphocyte-activation gene 3 (LAG-3) is a cell surface marker predominantly expressed in CD3-positive T cells with low expression in normal or malignant B cells, NK cells, and myeloid cells 35 and in PD-1-positive CD8+ and CD4+ tumor-infiltrating lymphocytes.